Is zidovudine therapy in pregnant HIV-infected women associated with gestational age and birthweight?

AIDS

Volumn 13, Issue 1, 1999, Pages 119-124

  Bailey, Andrea J ^a   Newell, Marie Louise ^a   Peckham, Catherine S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Birthweight; Europe; Prematurity; Vertical transmission; Zidovudine

Indexed keywords

ZIDOVUDINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NEWBORN; PREMATURITY; PRIORITY JOURNAL; RISK ASSESSMENT; VERTICAL TRANSMISSION;

ANTI-HIV AGENTS; BIRTH WEIGHT; CD4 LYMPHOCYTE COUNT; FEMALE; GESTATIONAL AGE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REVERSE TRANSCRIPTASE INHIBITORS; ZIDOVUDINE;

EID: 0032991193     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199901140-00016     Document Type: Article

References (20)

1. 1. Connor EM, Sperling RS, Gelber R, et al.: Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Eng J Med 1994, 331:1173-1180.
2. 2. Sperling RS, Shapiro DE, Coombs RW, et al.: Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Eng J Med 1996, 335:1621-1629.
3. 3. Vuthipongse P, Bhadrakom C, Chaisilwattana P, et al.: Administration of Zidovudine During Late Pregnancy and Delivery to Prevent Perinantal HIV Transmission - Thailand, 1996-1998. MMWR 1998, 47:151-154.
4. 4. Coll O, Hernandez M, Boucher CAB, et al.: Vertical HIV-1 transmission correlates with a high maternal viral load at delivery. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 14:26-30.
5. 5. Fang G, Burger H, Grimson R, et al.: Maternal plasma human immunodefiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission. Proc Natl Acad Sci, USA 1995, 92:12 100-104.
6. 6. Thea DM, Steketee RW, Pliner V, et al.: The effect of maternal viral load on the risk of perinatal transmission of HIV-1. AIDS 1997, 11:437-444.
7. 7. Mayaux MJ, Dussaix E, Isopet J, et al.: Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. J Infect Dis 1997, 175:172-175.
8. 8. Boyer PJ, Dillon M, Navaie M, et al.: Factors predictive of maternal-fetal transmission of HIV-1. JAMA 1994, 271:1925-1930.
9. 9. European Collaborative Study: Vertical transmission of HIV-1: maternal immune status and obstetric factors. AIDS 1996, 10:1675-1681.
10. 10. Mandelbrot L, Mayaux MJ, Bongain A, et al.: Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. Am J Obstet Gynecol 1996, 175:661-667.
11. 11. Kuhn L, Stein ZA, Thomas PA, Singh T, Tsai WY: Maternal-infant HIV transmission and circumstances of delivery. Am J Public Health 1994, 84:1110-1115.
12. 12. Newell ML, Gray G, Bryson YJ: Prevention of mother-to-child transmission of HIV-1 infection. AIDS 1997, 11(suppl A):S165-S172.
13. 13. O'Shea S, Newell ML, Dunn D, et al.: Maternal viral load, CD4 cell count and vertical transmission of HIV-1. J Med Virol 1998, 54:113-117.
14. 14. Thomson AM, Billewicz WZ, Hytten FE: The assessment of fetal growth. J Obstet Gynaecol Br Cwlth 1968, 75:903-916.
15. 15. Breslow N, Day N: The design and analysis of cohort studies. In: Statistical Methods in Cancer Research. Lyon, WHO International Agency for Research on Cancer IARC Scientific Publications; 1987; 52:406.
16. 16. European Collaborative Study: Therapeutic and other interventions to reduce the risk of mother-to-child transmission of HIV-1 in Europe. Br J Obstet Gynaecol 1998, 105:704-709.
17. 17. Tovo P, de Martino M, Gabiano C, et al.: Mode of delivery and gestational age influence perinatal HIV-1 transmission. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 11:88-94.
18. 18. Matheson PB, Abrams EJ, Thomas PA, et al.: Efficacy of antenatal zidovudine in reducing perinatal transmission of human immunodeficiency virus type 1. J Infect Dis 1995, 172:353-358.
19. 19. Cooper ER, Nugent RP, Pitt J, et al.: After AIDS clinical trial 076: the changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. J Infect Dis 1996, 174:1207-1211.
20. 20. Simonds RJ, Steketee R, Nesheim S, et al.: Impact of zidovudine use on risk and risk factors for perinatal transmission of HIV. AIDS 1998, 12:301-308.